-
1
-
-
77955048946
-
-
AHA. Metabolic syndrome: new guidance for prevention and treatment. AHA and NHLBI Scientific Statement.
-
AHA. Metabolic syndrome: new guidance for prevention and treatment. AHA and NHLBI Scientific Statement 2005.
-
(2005)
-
-
-
2
-
-
0032751075
-
Antipsychotic-induced weight gain: a comprehensive research synthesis
-
Allison D.B., Mentore J.L., Heo M., Chandler L.P., Cappelleri J.C., Infante M.C., et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999, 156:1686-1696.
-
(1999)
Am J Psychiatry
, vol.156
, pp. 1686-1696
-
-
Allison, D.B.1
Mentore, J.L.2
Heo, M.3
Chandler, L.P.4
Cappelleri, J.C.5
Infante, M.C.6
-
3
-
-
0033361056
-
Pharmacokinetics and tissue distribution of olanzapine in rats
-
Aravagiri M., Teper Y., Marder S.R. Pharmacokinetics and tissue distribution of olanzapine in rats. Biopharm Drug Dispos 1999, 20:369-377.
-
(1999)
Biopharm Drug Dispos
, vol.20
, pp. 369-377
-
-
Aravagiri, M.1
Teper, Y.2
Marder, S.R.3
-
4
-
-
49749133879
-
The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063
-
Assie M.B., Carilla-Durand E., Bardin L., Maraval M., Aliaga M., Malfetes N., et al. The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063. Eur J Pharmacol 2008, 592:160-166.
-
(2008)
Eur J Pharmacol
, vol.592
, pp. 160-166
-
-
Assie, M.B.1
Carilla-Durand, E.2
Bardin, L.3
Maraval, M.4
Aliaga, M.5
Malfetes, N.6
-
5
-
-
0027321081
-
Tissue concentrations of clozapine and its metabolites in the rat
-
Baldessarini R.J., Centorrino F., Flood J.G., Volpicelli S.A., Huston-Lyons D., Cohen B.M. Tissue concentrations of clozapine and its metabolites in the rat. Neuropsychopharmacology 1993, 9:117-124.
-
(1993)
Neuropsychopharmacology
, vol.9
, pp. 117-124
-
-
Baldessarini, R.J.1
Centorrino, F.2
Flood, J.G.3
Volpicelli, S.A.4
Huston-Lyons, D.5
Cohen, B.M.6
-
6
-
-
57049134614
-
Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague-Dawley rats
-
Cacho J., Sevillano J., de Castro J., Herrera E., Ramos M.P. Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague-Dawley rats. Am J Physiol Endocrinol Metab 2008, 295:E1269-E1276.
-
(2008)
Am J Physiol Endocrinol Metab
, vol.295
-
-
Cacho, J.1
Sevillano, J.2
de Castro, J.3
Herrera, E.4
Ramos, M.P.5
-
7
-
-
0026564595
-
Linear pharmacokinetics of haloperidol in the rat
-
Cheng Y.F., Paalzow L.K. Linear pharmacokinetics of haloperidol in the rat. Biopharm Drug Dispos 1992, 13:69-76.
-
(1992)
Biopharm Drug Dispos
, vol.13
, pp. 69-76
-
-
Cheng, Y.F.1
Paalzow, L.K.2
-
8
-
-
58149109332
-
Insulin resistance and decreased glucose-stimulated insulin secretion after acute olanzapine administration
-
Chintoh A.F., Mann S.W., Lam L., Lam C., Cohn T.A., Fletcher P.J., et al. Insulin resistance and decreased glucose-stimulated insulin secretion after acute olanzapine administration. J Clin Psychopharmacol 2008, 28:494-499.
-
(2008)
J Clin Psychopharmacol
, vol.28
, pp. 494-499
-
-
Chintoh, A.F.1
Mann, S.W.2
Lam, L.3
Lam, C.4
Cohn, T.A.5
Fletcher, P.J.6
-
9
-
-
50249172922
-
Insulin resistance following continuous, chronic olanzapine treatment: an animal model
-
Chintoh A.F., Mann S.W., Lam T.K., Giacca A., Remington G. Insulin resistance following continuous, chronic olanzapine treatment: an animal model. Schizophr Res 2008, 104:23-30.
-
(2008)
Schizophr Res
, vol.104
, pp. 23-30
-
-
Chintoh, A.F.1
Mann, S.W.2
Lam, T.K.3
Giacca, A.4
Remington, G.5
-
10
-
-
60249097928
-
Insulin resistance and secretion in vivo: effects of different antipsychotics in an animal model
-
Chintoh A.F., Mann S.W., Lam L., Giacca A., Fletcher P., Nobrega J., et al. Insulin resistance and secretion in vivo: effects of different antipsychotics in an animal model. Schizophr Res 2009, 108:127-133.
-
(2009)
Schizophr Res
, vol.108
, pp. 127-133
-
-
Chintoh, A.F.1
Mann, S.W.2
Lam, L.3
Giacca, A.4
Fletcher, P.5
Nobrega, J.6
-
11
-
-
34447575781
-
Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities
-
Cooper G.D., Pickavance L.C., Wilding J.P., Harrold J.A., Halford J.C., Goudie A.J. Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities. J Psychopharmacol 2007, 21:405-413.
-
(2007)
J Psychopharmacol
, vol.21
, pp. 405-413
-
-
Cooper, G.D.1
Pickavance, L.C.2
Wilding, J.P.3
Harrold, J.A.4
Halford, J.C.5
Goudie, A.J.6
-
12
-
-
38749111141
-
Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain
-
Cooper G.D., Harrold J.A., Halford J.C., Goudie A.J. Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:428-436.
-
(2008)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.32
, pp. 428-436
-
-
Cooper, G.D.1
Harrold, J.A.2
Halford, J.C.3
Goudie, A.J.4
-
13
-
-
33748786233
-
Food intake and reward mechanisms in patients with schizophrenia: implications for metabolic disturbances and treatment with second-generation antipsychotic agents
-
Elman I., Borsook D., Lukas S.E. Food intake and reward mechanisms in patients with schizophrenia: implications for metabolic disturbances and treatment with second-generation antipsychotic agents. Neuropsychopharmacology 2006, 31:2091-2120.
-
(2006)
Neuropsychopharmacology
, vol.31
, pp. 2091-2120
-
-
Elman, I.1
Borsook, D.2
Lukas, S.E.3
-
14
-
-
34648835121
-
The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats
-
Fell M.J., Anjum N., Dickinson K., Marshall K.M., Peltola L.M., Vickers S., et al. The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats. Psychopharmacology (Berl) 2007, 194:221-231.
-
(2007)
Psychopharmacology (Berl)
, vol.194
, pp. 221-231
-
-
Fell, M.J.1
Anjum, N.2
Dickinson, K.3
Marshall, K.M.4
Peltola, L.M.5
Vickers, S.6
-
15
-
-
0034917841
-
Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review
-
Geyer M.A., Krebs-Thomson K., Braff D.L., Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) 2001, 156:117-154.
-
(2001)
Psychopharmacology (Berl)
, vol.156
, pp. 117-154
-
-
Geyer, M.A.1
Krebs-Thomson, K.2
Braff, D.L.3
Swerdlow, N.R.4
-
16
-
-
0031727960
-
Saphenous vein puncture for blood sampling of the mouse, rat, hamster, gerbil, guinea pig, ferret and mink
-
Hem A., Smith A.J., Solberg P. Saphenous vein puncture for blood sampling of the mouse, rat, hamster, gerbil, guinea pig, ferret and mink. Lab Anim 1998, 32:364-368.
-
(1998)
Lab Anim
, vol.32
, pp. 364-368
-
-
Hem, A.1
Smith, A.J.2
Solberg, P.3
-
17
-
-
35648948443
-
Weight gain with atypical antipsychotics: evidence and insights
-
Henderson D.C. Weight gain with atypical antipsychotics: evidence and insights. J Clin Psychiatry 2007, 68(Suppl 12):18-26.
-
(2007)
J Clin Psychiatry
, vol.68
, Issue.SUPPL 12
, pp. 18-26
-
-
Henderson, D.C.1
-
18
-
-
34548097526
-
Conceptual and methodological issues in the design of clinical trials of antipsychotics for the treatment of schizophrenia
-
Honer W.G., Thornton A.E., Sherwood M., MacEwan G.W., Ehmann T.S., Williams R., et al. Conceptual and methodological issues in the design of clinical trials of antipsychotics for the treatment of schizophrenia. CNS Drugs 2007, 21:699-714.
-
(2007)
CNS Drugs
, vol.21
, pp. 699-714
-
-
Honer, W.G.1
Thornton, A.E.2
Sherwood, M.3
MacEwan, G.W.4
Ehmann, T.S.5
Williams, R.6
-
19
-
-
33846264544
-
Acute effects of atypical antipsychotics on whole-body insulin resistance in rats: implications for adverse metabolic effects
-
Houseknecht K.L., Robertson A.S., Zavadoski W., Gibbs E.M., Johnson D.E., Rollema H. Acute effects of atypical antipsychotics on whole-body insulin resistance in rats: implications for adverse metabolic effects. Neuropsychopharmacology 2007, 32:289-297.
-
(2007)
Neuropsychopharmacology
, vol.32
, pp. 289-297
-
-
Houseknecht, K.L.1
Robertson, A.S.2
Zavadoski, W.3
Gibbs, E.M.4
Johnson, D.E.5
Rollema, H.6
-
20
-
-
0032821965
-
Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp
-
Matsuda M., DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diab Care 1999, 22:1462-1470.
-
(1999)
Diab Care
, vol.22
, pp. 1462-1470
-
-
Matsuda, M.1
DeFronzo, R.A.2
-
21
-
-
0842328609
-
Clozapine and olanzapine, but not conventional antipsychotics, increase insulin release in vitro
-
Melkersson K. Clozapine and olanzapine, but not conventional antipsychotics, increase insulin release in vitro. Eur Neuropsychopharmacol 2004, 14:115-119.
-
(2004)
Eur Neuropsychopharmacol
, vol.14
, pp. 115-119
-
-
Melkersson, K.1
-
22
-
-
37849041094
-
Effects of the atypical antipsychotic clozapine on insulin release in vitro
-
Melkersson K., Jansson E. Effects of the atypical antipsychotic clozapine on insulin release in vitro. Neuro Endocrinol Lett 2007, 28:854-860.
-
(2007)
Neuro Endocrinol Lett
, vol.28
, pp. 854-860
-
-
Melkersson, K.1
Jansson, E.2
-
23
-
-
0942287757
-
Evaluation of insulin sensitivity in clinical practice and in research settings
-
Monzillo L.U., Hamdy O. Evaluation of insulin sensitivity in clinical practice and in research settings. Nutr Rev 2003, 61:397-412.
-
(2003)
Nutr Rev
, vol.61
, pp. 397-412
-
-
Monzillo, L.U.1
Hamdy, O.2
-
24
-
-
38349006256
-
Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage
-
Muniyappa R., Lee S., Chen H., Quon M.J. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008, 294:E15-E26.
-
(2008)
Am J Physiol Endocrinol Metab
, vol.294
-
-
Muniyappa, R.1
Lee, S.2
Chen, H.3
Quon, M.J.4
-
25
-
-
34547546693
-
Acute administration of clozapine concurrently increases blood glucose and circulating plasma ghrelin levels in rats
-
Murashita M., Kusumi I., Hosoda H., Kangawa K., Koyama T. Acute administration of clozapine concurrently increases blood glucose and circulating plasma ghrelin levels in rats. Psychoneuroendocrinology 2007, 32:777-784.
-
(2007)
Psychoneuroendocrinology
, vol.32
, pp. 777-784
-
-
Murashita, M.1
Kusumi, I.2
Hosoda, H.3
Kangawa, K.4
Koyama, T.5
-
26
-
-
18744366088
-
Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review
-
Newcomer J.W. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 2005, 19(Suppl 1):1-93.
-
(2005)
CNS Drugs
, vol.19
, Issue.SUPPL 1
, pp. 1-93
-
-
Newcomer, J.W.1
-
27
-
-
34248562315
-
Antipsychotic medications: metabolic and cardiovascular risk
-
Newcomer J.W. Antipsychotic medications: metabolic and cardiovascular risk. J Clin Psychiatry 2007, 68(Suppl 4):8-13.
-
(2007)
J Clin Psychiatry
, vol.68
, Issue.SUPPL 4
, pp. 8-13
-
-
Newcomer, J.W.1
-
28
-
-
33750459719
-
Elevation of systolic blood pressure in an animal model of olanzapine induced weight gain
-
Patil B.M., Kulkarni N.M., Unger B.S. Elevation of systolic blood pressure in an animal model of olanzapine induced weight gain. Eur J Pharmacol 2006, 551:112-115.
-
(2006)
Eur J Pharmacol
, vol.551
, pp. 112-115
-
-
Patil, B.M.1
Kulkarni, N.M.2
Unger, B.S.3
-
29
-
-
34848827473
-
Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatment
-
Procyshyn R.M., Wasan K.M., Thornton A.E., Barr A.M., Chen E.Y., Pomarol-Clotet E., et al. Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatment. J Psychiatry Neurosci 2007, 32:331-338.
-
(2007)
J Psychiatry Neurosci
, vol.32
, pp. 331-338
-
-
Procyshyn, R.M.1
Wasan, K.M.2
Thornton, A.E.3
Barr, A.M.4
Chen, E.Y.5
Pomarol-Clotet, E.6
-
30
-
-
77952633076
-
-
Persistent antipsychotic polypharmacy and excessive dosing in the community psychiatric treatment setting. J Clin Psychiatry.
-
Procyshyn RM, Honer WG, Wu TKY, Ko RWY, McIsaac SA, Young AH, et al. Persistent antipsychotic polypharmacy and excessive dosing in the community psychiatric treatment setting. J Clin Psychiatry 2010;71(5):566-573.
-
(2010)
, vol.71
, Issue.5
, pp. 566-573
-
-
Procyshyn, R.M.1
Honer, W.G.2
Wu, T.K.Y.3
Ko, R.W.Y.4
McIsaac, S.A.5
Young, A.H.6
-
31
-
-
33750077822
-
Do certain atypical antipsychotics increase the risk of diabetes? A critical review of 17 pharmacoepidemiologic studies
-
Ramaswamy K., Masand P.S., Nasrallah H.A. Do certain atypical antipsychotics increase the risk of diabetes? A critical review of 17 pharmacoepidemiologic studies. Ann Clin Psychiatry 2006, 18:183-194.
-
(2006)
Ann Clin Psychiatry
, vol.18
, pp. 183-194
-
-
Ramaswamy, K.1
Masand, P.S.2
Nasrallah, H.A.3
-
32
-
-
0033377929
-
Conventional versus novel antipsychotics: changing concepts and clinical implications
-
Remington G., Chong S.A. Conventional versus novel antipsychotics: changing concepts and clinical implications. J Psychiatry Neurosci 1999, 24:431-441.
-
(1999)
J Psychiatry Neurosci
, vol.24
, pp. 431-441
-
-
Remington, G.1
Chong, S.A.2
-
33
-
-
34447534307
-
Schizophrenia, antipsychotics and metabolic disease
-
Reynolds G.P. Schizophrenia, antipsychotics and metabolic disease. J Psychopharmacol 2007, 21:355-356.
-
(2007)
J Psychopharmacol
, vol.21
, pp. 355-356
-
-
Reynolds, G.P.1
-
34
-
-
0037317444
-
Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia
-
Ryan M.C., Collins P., Thakore J.H. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry 2003, 160:284-289.
-
(2003)
Am J Psychiatry
, vol.160
, pp. 284-289
-
-
Ryan, M.C.1
Collins, P.2
Thakore, J.H.3
-
35
-
-
43649093613
-
Effects of olanzapine and ziprasidone on glucose tolerance in healthy volunteers
-
Sacher J., Mossaheb N., Spindelegger C., Klein N., Geiss-Granadia T., Sauermann R., et al. Effects of olanzapine and ziprasidone on glucose tolerance in healthy volunteers. Neuropsychopharmacology 2008, 33:1633-1641.
-
(2008)
Neuropsychopharmacology
, vol.33
, pp. 1633-1641
-
-
Sacher, J.1
Mossaheb, N.2
Spindelegger, C.3
Klein, N.4
Geiss-Granadia, T.5
Sauermann, R.6
-
36
-
-
55649115291
-
Atypical antipsychotic drugs induce derangements in glucose homeostasis by acutely increasing glucagon secretion and hepatic glucose output in the rat
-
Smith G.C., Chaussade C., Vickers M., Jensen J., Shepherd P.R. Atypical antipsychotic drugs induce derangements in glucose homeostasis by acutely increasing glucagon secretion and hepatic glucose output in the rat. Diabetologia 2008, 51:2309-2317.
-
(2008)
Diabetologia
, vol.51
, pp. 2309-2317
-
-
Smith, G.C.1
Chaussade, C.2
Vickers, M.3
Jensen, J.4
Shepherd, P.R.5
-
37
-
-
70349423412
-
Clozapine and quetiapine acutely reduce glucagon-like peptide-1 production and increase glucagon release in obese rats: implications for glucose metabolism and food choice behaviour
-
Smith G.C., Vickers M.H., Cognard E., Shepherd P.R. Clozapine and quetiapine acutely reduce glucagon-like peptide-1 production and increase glucagon release in obese rats: implications for glucose metabolism and food choice behaviour. Schiz Res 2009, 115:30-40.
-
(2009)
Schiz Res
, vol.115
, pp. 30-40
-
-
Smith, G.C.1
Vickers, M.H.2
Cognard, E.3
Shepherd, P.R.4
-
38
-
-
34248161538
-
Clozapine-induced alteration of glucose homeostasis in the rat: the contribution of hypothalamic-pituitary-adrenal axis activation
-
Tulipano G., Rizzetti C., Bianchi I., Fanzani A., Spano P., Cocchi D. Clozapine-induced alteration of glucose homeostasis in the rat: the contribution of hypothalamic-pituitary-adrenal axis activation. Neuroendocrinology 2007, 85:61-70.
-
(2007)
Neuroendocrinology
, vol.85
, pp. 61-70
-
-
Tulipano, G.1
Rizzetti, C.2
Bianchi, I.3
Fanzani, A.4
Spano, P.5
Cocchi, D.6
-
39
-
-
0028333931
-
Regional brain distribution of risperidone and its active metabolite 9-hydroxy-risperidone in the rat
-
van Beijsterveldt L.E., Geerts R.J., Leysen J.E., Megens A.A., Van den Eynde H.M., Meuldermans W.E., et al. Regional brain distribution of risperidone and its active metabolite 9-hydroxy-risperidone in the rat. Psychopharmacology (Berl) 1994, 114:53-62.
-
(1994)
Psychopharmacology (Berl)
, vol.114
, pp. 53-62
-
-
van Beijsterveldt, L.E.1
Geerts, R.J.2
Leysen, J.E.3
Megens, A.A.4
Van den Eynde, H.M.5
Meuldermans, W.E.6
|